Hi {{lead.First Name:default=edit me}},

You know that human biospecimens represent the best research model, but accessing the right human samples can be challenging. Fortunately, Anokion’s pipeline matches well with Sanguine’s network of highly characterized, recallable patient donors, so you can choose I/E criteria and timely receive the right samples, including PBMCs and leukopaks. Search Sanguine’s nationwide donor network, which includes:

  • >26,000 donors with autoimmune indications, our most diverse patient group
  • >2,000 donors with metabolic diseases, including diabetes (type I & II)

Anokion’s commitment to treating inflammatory conditions and Sanguine’s goal of connecting patients to researchers explains why our companies have partnered on studies leading to clinical trial success. Let’s discuss whether we can continue succeeding for patients.

Warm regards,

Brianna Van Ness
Account Executive
Sanguine Bio | Massachusetts

Schedule a Meeting
| www.sanguinebio.com